Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Gene | ATRX |
Variant | fusion |
Impact List | fusion |
Protein Effect | unknown |
Gene Variant Descriptions | ATRX fusion indicates a fusion of the ATRX gene, but the fusion partner is unknown. |
Associated Drug Resistance | |
Category Variants Paths |
ATRX mutant ATRX fusion |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
ATRX fusion | neuroblastoma | predicted - sensitive | UNC1999 | Preclinical - Cell line xenograft | Actionable | In a preclinical study, treatment with UNC1999 resulted in reduced proliferation and increased apoptosis of neuroblastoma cell lines harboring in-frame ATRX fusions in culture, and decreased tumor growth in a neuroblastoma cell line xenograft model harboring an ATRX fusion (PMID: 31631027). | 31631027 |
ATRX fusion | neuroblastoma | predicted - sensitive | Tazemetostat | Preclinical - Cell culture | Actionable | In a preclinical study, treatment with Tazemetostat (EPZ-6438) resulted in reduced proliferation and increased apoptosis of neuroblastoma cell lines harboring in-frame ATRX fusions in culture (PMID: 31631027). | 31631027 |
ATRX fusion | neuroblastoma | predicted - sensitive | GSK126 | Preclinical - Cell culture | Actionable | In a preclinical study, treatment with GSK126 resulted in reduced proliferation and increased apoptosis of neuroblastoma cell lines harboring in-frame ATRX fusions in culture (PMID: 31631027). | 31631027 |